Suvretta Capital Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Suvretta Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $2.59 Million - $7.45 Million	-406,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $5.03 Million - $7.76 Million	406,200 New	406,200 $6.76 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $816,300 - $1.23 Million	-30,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $586,200 - $1.17 Million	30,000 New	30,000 $898,000

319

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $958M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.